Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA BIOCON ABBOTT INDIA/
BIOCON
 
P/E (TTM) x 49.1 35.8 137.1% View Chart
P/BV x 15.6 4.0 387.7% View Chart
Dividend Yield % 1.3 0.2 744.3%  

Financials

 ABBOTT INDIA   BIOCON
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-22
BIOCON
Mar-22
ABBOTT INDIA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs23,902424 5,636.0%   
Low Rs14,553315 4,621.4%   
Sales per share (Unadj.) Rs2,315.068.2 3,396.1%  
Earnings per share (Unadj.) Rs375.98.2 4,611.7%  
Cash flow per share (Unadj.) Rs407.014.9 2,725.5%  
Dividends per share (Unadj.) Rs275.000.50 55,000.0%  
Avg Dividend yield %1.40.1 1,056.9%  
Book value per share (Unadj.) Rs1,306.268.5 1,905.8%  
Shares outstanding (eoy) m21.251,200.60 1.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.35.4 153.2%   
Avg P/E ratio x51.245.3 112.8%  
P/CF ratio (eoy) x47.224.7 190.9%  
Price / Book Value ratio x14.75.4 273.0%  
Dividend payout %73.26.1 1,192.6%   
Avg Mkt Cap Rs m408,573443,622 92.1%   
No. of employees `000NANA-   
Total wages/salary Rs m5,79518,801 30.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m49,19381,840 60.1%  
Other income Rs m7746,891 11.2%   
Total revenues Rs m49,96788,731 56.3%   
Gross profit Rs m10,87513,827 78.7%  
Depreciation Rs m6618,142 8.1%   
Interest Rs m191676 28.3%   
Profit before tax Rs m10,79711,900 90.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,8102,115 132.9%   
Profit after tax Rs m7,9879,785 81.6%  
Gross profit margin %22.116.9 130.9%  
Effective tax rate %26.017.8 146.4%   
Net profit margin %16.212.0 135.8%  
BALANCE SHEET DATA
Current assets Rs m38,53083,823 46.0%   
Current liabilities Rs m12,03238,280 31.4%   
Net working cap to sales %53.955.6 96.8%  
Current ratio x3.22.2 146.2%  
Inventory Days Days6101 6.1%  
Debtors Days Days292 2.3%  
Net fixed assets Rs m3,541117,184 3.0%   
Share capital Rs m2136,003 3.5%   
"Free" reserves Rs m27,54476,281 36.1%   
Net worth Rs m27,75682,284 33.7%   
Long term debt Rs m039,985 0.0%   
Total assets Rs m42,072201,007 20.9%  
Interest coverage x57.518.6 309.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 287.2%   
Return on assets %19.45.2 373.5%  
Return on equity %28.811.9 242.0%  
Return on capital %39.610.3 384.9%  
Exports to sales %0.70-   
Imports to sales %10.27.8 131.7%   
Exports (fob) Rs m350NA-   
Imports (cif) Rs m5,0346,360 79.1%   
Fx inflow Rs m4158,885 4.7%   
Fx outflow Rs m5,1176,360 80.5%   
Net fx Rs m-4,7022,525 -186.2%   
CASH FLOW
From Operations Rs m9,47711,766 80.5%  
From Investments Rs m-3,958-16,991 23.3%  
From Financial Activity Rs m-6,3742,421 -263.3%  
Net Cashflow Rs m-856-2,433 35.2%  

Share Holding

Indian Promoters % 0.0 39.7 -  
Foreign collaborators % 75.0 21.0 357.4%  
Indian inst/Mut Fund % 8.1 23.6 34.2%  
FIIs % 0.2 15.8 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 39.4 63.5%  
Shareholders   83,526 369,816 22.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Abbott India vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Abbott India vs Biocon Share Price Performance

Period Abbott India Biocon S&P BSE HEALTHCARE
1-Day 0.81% 0.04% -0.89%
1-Month 6.06% -1.09% -1.85%
1-Year 7.50% -28.00% -6.83%
3-Year CAGR 16.90% -1.61% 20.56%
5-Year CAGR 29.35% -11.97% 10.73%

* Compound Annual Growth Rate

Here are more details on the Abbott India share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Abbott India hold a 75.0% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Abbott India and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Abbott India paid a dividend of Rs 275.0 per share. This amounted to a Dividend Payout ratio of 73.2%.

Biocon paid Rs 0.5, and its dividend payout ratio stood at 6.1%.

You may visit here to review the dividend history of Abbott India, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

NTPC to Build Nuclear Fleet | Inox Group's Big Fundraise to Pare Debt | Top Buzzing Stocks Today(Pre-Open)

On Thursday, Indian share markets extended gains during the last hour of trade to end higher.